Amphastar Pharmaceuticals Inc (AMPH)

50.64 -0.09 (-0.18%) USD  |  NASDAQ  |  Nov 04, 13:04
More

Amphastar Pharmaceuticals Debt to Equity Ratio: 0.823 for June 30, 2024

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Upgrade now.
Date Value
June 30, 2024 0.823
March 31, 2024 0.8841
December 31, 2023 0.9227
September 30, 2023 1.073
June 30, 2023 0.8506
March 31, 2023 0.1368
December 31, 2022 0.1435
September 30, 2022 0.1498
June 30, 2022 0.1521
March 31, 2022 0.1595
December 31, 2021 0.1728
September 30, 2021 0.1809
June 30, 2021 0.0913
March 31, 2021 0.1097
December 31, 2020 0.1155
September 30, 2020 0.1112
June 30, 2020 0.1174
March 31, 2020 0.1268
December 31, 2019 0.1236
September 30, 2019 0.1157
June 30, 2019 0.1205
March 31, 2019 0.145
Date Value
December 31, 2018 0.151
September 30, 2018 0.1603
June 30, 2018 0.1641
March 31, 2018 0.1399
December 31, 2017 0.1413
September 30, 2017 0.1465
June 30, 2017 0.1389
March 31, 2017 0.1118
December 31, 2016 0.1146
September 30, 2016 0.13
June 30, 2016 0.1387
March 31, 2016 0.1358
December 31, 2015 0.1391
September 30, 2015 0.1625
June 30, 2015 0.1663
March 31, 2015 0.1734
December 31, 2014 0.155
September 30, 2014 0.1814
June 30, 2014 0.186
March 31, 2014 0.165
December 31, 2013 0.1279

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

0.0913
Minimum
Jun 2021
1.073
Maximum
Sep 2023
0.3392
Average
0.1498
Median
Sep 2022

Debt to Equity Ratio Benchmarks

Omeros Corp --
Harrow Inc 3.161
PetIQ Inc 1.717
Alector Inc 0.00
Outset Medical Inc 2.872

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 1.492B
Total Liabilities (Quarterly) 778.18M
Shareholders Equity (Quarterly) 713.35M
Current Ratio 3.524
Net Debt Paydown Yield -5.23%